1. Home
  2. MVBF vs GNFT Comparison

MVBF vs GNFT Comparison

Compare MVBF & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MVBF
  • GNFT
  • Stock Information
  • Founded
  • MVBF 1997
  • GNFT 1999
  • Country
  • MVBF United States
  • GNFT France
  • Employees
  • MVBF N/A
  • GNFT N/A
  • Industry
  • MVBF Major Banks
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MVBF Finance
  • GNFT Health Care
  • Exchange
  • MVBF Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • MVBF 281.6M
  • GNFT 189.6M
  • IPO Year
  • MVBF N/A
  • GNFT 2019
  • Fundamental
  • Price
  • MVBF $20.03
  • GNFT $3.80
  • Analyst Decision
  • MVBF Buy
  • GNFT Strong Buy
  • Analyst Count
  • MVBF 2
  • GNFT 1
  • Target Price
  • MVBF $27.50
  • GNFT $13.00
  • AVG Volume (30 Days)
  • MVBF 37.5K
  • GNFT 9.8K
  • Earning Date
  • MVBF 02-12-2025
  • GNFT 09-19-2024
  • Dividend Yield
  • MVBF 3.20%
  • GNFT N/A
  • EPS Growth
  • MVBF N/A
  • GNFT N/A
  • EPS
  • MVBF 1.41
  • GNFT 0.47
  • Revenue
  • MVBF $140,251,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • MVBF N/A
  • GNFT $155.44
  • Revenue Next Year
  • MVBF $7.90
  • GNFT N/A
  • P/E Ratio
  • MVBF $15.10
  • GNFT $7.53
  • Revenue Growth
  • MVBF N/A
  • GNFT 175.45
  • 52 Week Low
  • MVBF $17.51
  • GNFT $3.31
  • 52 Week High
  • MVBF $25.24
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • MVBF 36.07
  • GNFT 29.24
  • Support Level
  • MVBF $21.51
  • GNFT $3.63
  • Resistance Level
  • MVBF $21.27
  • GNFT $3.88
  • Average True Range (ATR)
  • MVBF 0.58
  • GNFT 0.10
  • MACD
  • MVBF -0.25
  • GNFT 0.02
  • Stochastic Oscillator
  • MVBF 10.91
  • GNFT 15.30

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides community banking, mortgage banking, insurance and wealth management services to individuals and corporate clients in the Mid-Atlantic region. The Bank offers its customers various products, such as checking accounts, negotiable order of withdrawal (NOW) accounts, money market and savings accounts, time certificates of deposit, commercial, installment, commercial real estate and residential real estate mortgage loans, debit cards, and safe deposit rental facilities. MVB has three reportable segments: CoRe banking; mortgage banking and the financial holding company. It generates majority of its revenues from its CoRe banking segment.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: